title: Rituximab-associated colitis.
authors.forename: Mahesh
authors.initials: M
authors.lastname: Bhalme
authors.forename: Stephen
authors.initials: S
authors.lastname: Hayes
authors.forename: Andrew
authors.initials: A
authors.lastname: Norton
authors.forename: Simon
authors.initials: S
authors.lastname: Lal
authors.forename: Hector
authors.initials: H
authors.lastname: Chinoy
authors.forename: Peter
authors.initials: P
authors.lastname: Paine
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D003093:Colitis, Ulcerative / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis / Q000276:immunology; D005260:Female; D006801:Humans; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab